Cargando…
Chitosan Interferon-γ Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses
The use of chitosan nanoparticles as carriers for expression plasmids represents a major improvement in gene expression technology. We demonstrated previously that treatment with chitosan interferon-γ (IFN-γ) plasmid deoxyribonucleic acid (DNA) nanoparticles (chitosan interferon-γ nanogene [CIN]) le...
Autores principales: | Kong, Xiaoyuan, Hellermann, Gary R, Zhang, Weidong, Jena, Prasanna, Kumar, Mukesh, Behera, Aruna, Behera, Sumita, Lockey, Richard, Mohapatra, Shyam S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868869/ https://www.ncbi.nlm.nih.gov/pubmed/20525130 http://dx.doi.org/10.1186/1710-1492-4-3-95 |
Ejemplares similares
-
Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma
por: Kumar, Mukesh, et al.
Publicado: (2003) -
Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice
por: Singam, Rajeswari, et al.
Publicado: (2006) -
An immunocompromised BALB/c mouse model for respiratory syncytial virus infection
por: Kong, Xiaoyuan, et al.
Publicado: (2005) -
Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells
por: Zhang, Weidong, et al.
Publicado: (2011) -
Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells
por: Hellermann, Gary R, et al.
Publicado: (2002)